Daniel Glossman-Mitnik | Computational Biology | Best Academic Researcher Award

Published on by Technology Scientists

Dr. Daniel Glossman-Mitnik | Computational Biology | Best Academic Researcher Award

Emeritus Researcher|Center for Research in Advanced Materials | Mexico

Dr. Daniel Glossman-Mitnik is a prominent researcher at the Centro de Investigación en Materiales Avanzados (CIMAV), Chihuahua, Mexico, recognized internationally for his extensive contributions to computational and theoretical chemistry. His work primarily employs Density Functional Theory (DFT) and Conceptual DFT (CDFT) to investigate the structural, electronic, and reactive properties of molecules and materials relevant to nanotechnology, materials science, and bioactive compounds. With a prolific record of 62 peer-reviewed publications, his research has accumulated over 817 citations, achieving an h-index of 19, which reflects the sustained impact and academic quality of his scientific output. Dr. Glossman-Mitnik’s recent studies encompass a wide spectrum of applications, including the design of triphenylamine-based sensitizers and Cu(I) complexes for dye-sensitized solar cells (DSSCs), as well as computational evaluations of marine natural products and therapeutic peptides for drug discovery. His scholarly endeavors are characterized by interdisciplinary collaboration, having co-authored with more than 120 researchers worldwide, fostering innovation through theoretical–experimental integration. Beyond his methodological expertise, his research has meaningful social and technological implications, contributing to advancements in renewable energy materials, environmentally sustainable chemical design, and computational approaches to pharmacology. By combining rigorous quantum-chemical modeling with practical applications, Dr. Glossman-Mitnik’s work exemplifies how theoretical insights can drive real-world scientific progress. His career reflects a profound commitment to advancing the global understanding of molecular behavior and material performance, positioning him as a leading figure in contemporary computational chemistry.

Profiles: Scopus | Google Scholar

Featured Publications

1. Rodríguez-Valdez, L. M., Villamisar, W., Casales, M., González-Rodríguez, J. G., & others. (2006). Computational simulations of the molecular structure and corrosion properties of amidoethyl, aminoethyl and hydroxyethyl imidazolines inhibitors. Corrosion Science, 48(12), 4053–4064.
Cited by: 248

2. Rodríguez-Valdez, L. M., Martínez-Villafañe, A., & Glossman-Mitnik, D. (2005). Computational simulation of the molecular structure and properties of heterocyclic organic compounds with possible corrosion inhibition properties. Journal of Molecular Structure: THEOCHEM, 713(1), 65–70.
Cited by: 233

3. Glossman-Mitnik, D. (2013). Computational study of the chemical reactivity properties of the Rhodamine B molecule. Procedia Computer Science, 18, 816–825.
Cited by: 131

4. Mendoza-Wilson, A. M., & Glossman-Mitnik, D. (2006). Theoretical study of the molecular properties and chemical reactivity of (+)-catechin and (−)-epicatechin related to their antioxidant ability. Journal of Molecular Structure: THEOCHEM, 761(1), 97–106.
Cited by: 130

5. Gallo, M., Favila, A., & Glossman-Mitnik, D. (2007). DFT studies of functionalized carbon nanotubes and fullerenes as nanovectors for drug delivery of antitubercular compounds. Chemical Physics Letters, 447(1), 105–109.
Cited by: 128

Dr. Daniel Glossman-Mitnik’s work advances global innovation by integrating computational chemistry with materials science and biomedicine, enabling the rational design of sustainable materials and therapeutic compounds. His research bridges theory and application, contributing to cleaner energy technologies, drug discovery, and the broader understanding of molecular behavior for societal and industrial benefit.

Mansoureh Azadeh | Bioinformatics | Women Researcher Award

Published on by Technology Scientists

Dr. Mansoureh Azadeh | Bioinformatics | Women Researcher Award

Lab Manager | Zist Fanavari Novin Biotechnology Institute | Iran

Dr. Mansoureh Azadeh is a distinguished molecular and cellular biologist and the Founder and Director of Zist Fanavari Novin Biotechnology Institute in Isfahan, Iran. With over two decades of leadership in academia, research, and biotechnology entrepreneurship, she has significantly advanced cancer genomics, gene expression analysis, and personalized medicine. Her research spans diverse areas including breast cancer, cardiovascular disease, multiple sclerosis, drug resistance, and athletic genomics. In 2023, she founded PreventiGene, a genetics startup focused on early cancer detection. Dr. Azadeh has served as Chair of the Board at Control Tavan Novin Pouya since 2006, and has also managed the COVID-19 department at Jey Medical Diagnosis Laboratory. An active educator, she has taught for 20 semesters at Azad University and leads national technical training programs in biotechnology. She has authored books on laboratory methods and cancer diagnostics, serves as an editor for medical journals, and regularly collaborates with academic and industry partners to promote scientific innovation. She is widely recognized for her expertise in advanced technologies such as CRISPR, RNA sequencing, and high-throughput data analysis, and has developed and supervised numerous genetic research initiatives. Her technical skills span PCR/qPCR, ELISA, Western blotting, microbiology, and cell culture. As of October 2025, Dr. Azadeh has authored 34 indexed publications, with 313 citations, and holds an h-index of 13 , reflecting her impactful contribution to life sciences and translational research.

Profiles: Scopus | Google Scholar | LinkedIn | ResearchGate

Featured Publications

1. Bagheri, F., Mesrian Tanha, H., Mojtabavi Naeini, M., Ghaedi, K., & Azadeh, M. (2016). Tumor-promoting function of single nucleotide polymorphism rs1836724 (C3388T) alters multiple potential legitimate microRNA binding sites at the 3′-untranslated region of ErbB4. Molecular Medicine Reports, 13(5), 4494–4498. 
Cited by: 39

2. Ebrahimi Ghahnavieh, L., Tabatabaeian, H., Ebrahimi Ghahnavieh, Z., & others. (2020). Fluctuating expression of miR-584 in primary and high-grade gastric cancer. BMC Cancer, 20, 621. 
Cited by: 31

3. Noormohammad, M., Sadeghi, S., Tabatabaeian, H., Ghaedi, K., Talebi, A., & others. (2016). Upregulation of miR-222 in both Helicobacter pylori-infected and noninfected gastric cancer patients. Journal of Genetics, 95(4), 991–995. 
Cited by: 29

4. Fattahi Dolatabadi, N., Dehghani, A., Shahand, E., Yazdanshenas, M., & others. (2020). The interaction between MALAT1 target, miR-143-3p, and RALGAPA2 is affected by functional SNP rs3827693 in breast cancer. Human Cell, 33(4), 1229–1239.
Cited by: 28

5. Adami, B., Tabatabaeian, H., Ghaedi, K., Talebi, A., Azadeh, M., & Dehdashtian, E. (2019). miR-146a is deregulated in gastric cancer. Journal of Cancer Research and Therapeutics, 15(1), 108–114.
Cited by: 28